Correlation
The correlation between PAHC and BSX is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
PAHC vs. BSX
Compare and contrast key facts about Phibro Animal Health Corporation (PAHC) and Boston Scientific Corporation (BSX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PAHC or BSX.
Performance
PAHC vs. BSX - Performance Comparison
Loading data...
Key characteristics
PAHC:
0.82
BSX:
1.76
PAHC:
1.44
BSX:
2.29
PAHC:
1.17
BSX:
1.37
PAHC:
0.56
BSX:
2.61
PAHC:
2.73
BSX:
10.62
PAHC:
13.12%
BSX:
3.81%
PAHC:
48.07%
BSX:
22.34%
PAHC:
-79.60%
BSX:
-89.15%
PAHC:
-45.96%
BSX:
-2.02%
Fundamentals
PAHC:
$991.45M
BSX:
$157.07B
PAHC:
$0.78
BSX:
$1.39
PAHC:
31.36
BSX:
76.38
PAHC:
1.66
BSX:
2.57
PAHC:
0.83
BSX:
8.95
PAHC:
3.54
BSX:
6.96
PAHC:
$1.19B
BSX:
$17.55B
PAHC:
$376.71M
BSX:
$11.79B
PAHC:
$128.96M
BSX:
$4.09B
Returns By Period
The year-to-date returns for both stocks are quite close, with PAHC having a 17.25% return and BSX slightly lower at 17.01%. Over the past 10 years, PAHC has underperformed BSX with an annualized return of -1.38%, while BSX has yielded a comparatively higher 19.05% annualized return.
PAHC
17.25%
32.94%
4.38%
38.98%
11.27%
1.39%
-1.38%
BSX
17.01%
2.28%
15.16%
39.03%
36.38%
22.43%
19.05%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PAHC vs. BSX — Risk-Adjusted Performance Rank
PAHC
BSX
PAHC vs. BSX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
PAHC vs. BSX - Dividend Comparison
PAHC's dividend yield for the trailing twelve months is around 1.96%, while BSX has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAHC Phibro Animal Health Corporation | 1.96% | 2.29% | 4.15% | 3.58% | 2.35% | 2.47% | 1.93% | 1.31% | 1.19% | 1.37% | 1.33% | 0.63% |
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PAHC vs. BSX - Drawdown Comparison
The maximum PAHC drawdown since its inception was -79.60%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for PAHC and BSX.
Loading data...
Volatility
PAHC vs. BSX - Volatility Comparison
Phibro Animal Health Corporation (PAHC) has a higher volatility of 18.84% compared to Boston Scientific Corporation (BSX) at 4.51%. This indicates that PAHC's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
PAHC vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Phibro Animal Health Corporation and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PAHC vs. BSX - Profitability Comparison
PAHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Phibro Animal Health Corporation reported a gross profit of 104.57M and revenue of 347.83M. Therefore, the gross margin over that period was 30.1%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.
PAHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Phibro Animal Health Corporation reported an operating income of 33.52M and revenue of 347.83M, resulting in an operating margin of 9.6%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.
PAHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Phibro Animal Health Corporation reported a net income of 20.88M and revenue of 347.83M, resulting in a net margin of 6.0%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.